USPTO serial 76066567
MAXYGEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, BRIDGETT G
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MAXYGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Redwood City, CA
Redwood City, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
STEPHANIE K. WADE
STEPHANIE K WADE ARENT FOX KINTNER PLOTKIN & KAHN, PLLC1050 CONNECTICUT AVE N WWASHINGTON, DC 20036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemicals, namely, polynucleic acids and polypeptides for commercial use; biochemicals for in vitro and in vivo commercial use; genes for commercial applications pertaining to chemistry, biochemistry, biology, pharmaceuticals, diagnostics and medicine; genes for research applications pertaining to chemistry and diagnostics; enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, pharmaceuticals, diagnostics and medicine | ACTIVE | — |
| 005 | Pharmaceutical preparations for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, respiratory tract, and renal and urinary tract diseases and disorders; pharamaceutical preparations, namely, analgesics, antibotics, anti-cancer preparations, anti-infectives, anti-parasitics, antivirals; insulin; hormones; medical diagnostic preparations and reagents; vaccines; adjuvants for use with vaccines | ACTIVE | — |
| 042 | Chemical research services; testing services in the fields of bacteriology and virology; research and product development services for others in the fields gene therapy, chemistry, medical diagnostics; cytotoxic agents, metabolic pathways, , and other utilities | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Maxygen, Inc.
- Other trademarks owned by Maxygen, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MAXYGEN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 27, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 22, 2004 | PAPER RECEIVED | — | |
| Nov 20, 2004 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 20, 2004 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 21, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2004 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 27, 2004 | CFIT | CASE FILE IN TICRS | — |
| May 18, 2004 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 18, 2004 | PAPER RECEIVED | — | |
| Feb 7, 2004 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 7, 2004 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 5, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 18, 2003 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 18, 2003 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 18, 2003 | PAPER RECEIVED | — | |
| Jun 19, 2003 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 20, 2003 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 20, 2003 | PAPER RECEIVED | — | |
| Nov 7, 2002 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 6, 2002 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 2, 2002 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 2, 2002 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 2, 2002 | PAPER RECEIVED | — | |
| May 21, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 1, 2001 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 9, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 19, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 25, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2001 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Nov 3, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 2, 2000 | DOCK | ASSIGNED TO EXAMINER | — |